Moneycontrol
HomeNewsBusinessMarketsQ4 result impact: Dalmia Bharat Sugar shares up 9% as PAT more than doubles, GSK Pharma and AB Capital shares rise 5%
Trending Topics

Q4 result impact: Dalmia Bharat Sugar shares up 9% as PAT more than doubles, GSK Pharma and AB Capital shares rise 5%

Q4 result impact | GSK Pharma reported a 35% rise in net profit to Rs 263 crore in Q4 FY25, while Aditya Birla Capital reported a net profit of Rs 864.60 crore for the fourth quarter, lower by nearly 31 percent on year.

May 14, 2025 / 11:58 IST
Story continues below Advertisement
Q4 result impact: Dalmia Bharat Sugar shares jump 9% as net profit zooms 126%, GSK Pharma, AB Capital shares rise 5%

The shares of Dalmia Bharat Sugar surged nearly 9 percent on May 14 after the company reported a 126 percent rise in net profit at Rs 206 crore for the fourth quarter of the financial year 2025. GSK Pharma and Aditya Birla Capital shares too gained by around 5 percent each.

The companies had released their respective Q4FY25 results post-market hours on May 13.

Story continues below Advertisement

Dalmia Bharat Sugar

Sugar and industrial alcohol supplier Dalmia Bharat Sugar on May 13 reported a net profit of Rs 206 crore for Q4FY25, marking a 126 percent rise from the Rs 91 crore net profit reported a year ago. The revenue from operations meanwhile surged around 36 percent on-year to Rs 1,018 crore. The firm also reported its highest ever EBITDA at Rs 215 crore.